I hate seeing pharma leaders overwhelmed by GTN leakage.
Millions of dollars disappear because internal data alone can’t catch it.
The best pharma market access teams manned by the smartest and most experienced subject matter experts aren’t working with programs that are connected to data from other vendors’ systems.
At RIS Rx, we’re:
- Connecting to most copay vendor and most hubs
- Mapping out this data for a 360° view of the entire industry
- Integrating seamlessly into existing workflows
- Creating a dynamic rules engine that can keep up with evolving leakage
Working with “good enough” algorithms won’t give you drill-down visibility into cost per claim.
What’s more, pharma market access teams aren’t just focusing on patient affordability. They’re rebate optimization, launch readiness, etc. These teams are stretched thin and might only have time to look for outlier analysis.
Uncover overlooked savings, save time and money, and free up your teams for more valuable initiatives like better patient care.
Here’s an example of the savings we were actually able to uncover from a recent Savings Snapshot ↓
Our analytics uncover where dollars are leaking—and how RIS Rx solutions recover hundreds of millions in lost value.
